Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Radiopharm ; 15(3): 242-248, 2022.
Article in English | MEDLINE | ID: mdl-35319403

ABSTRACT

BACKGROUND: Radioresistance is found to be the main therapeutic restriction in colorectal radiation therapy. The aim of this study was to investigate the synergistic effect of Etodolac (ET) and ionizing radiation on human colorectal cancer cells. METHODS: Pretreated HT-29 cells with ET were exposed to ionizing radiation. The radiosensitizing effect of ET was evaluated using MTT, flow cytometry, and clonogenic assay. The amount of nitrite oxide (NO) in irradiated cells was also measured with the Griess reagent. RESULTS: The present study found that pretreatment of HT-29 cells with ET decreases their survival and colony formation. Higher concentrations of ET cause total apoptosis and an increase in NO levels in irradiated cells. CONCLUSION: Applying ET in a concentration-dependent manner had an incremental effect on the amount of apoptosis and cell death induced by radiation.


Subject(s)
Colorectal Neoplasms , Radiation-Sensitizing Agents , Apoptosis/radiation effects , Cell Line, Tumor , Colorectal Neoplasms/drug therapy , Colorectal Neoplasms/metabolism , Colorectal Neoplasms/radiotherapy , Etodolac/pharmacology , Etodolac/therapeutic use , HT29 Cells , Humans , Radiation Tolerance/radiation effects , Radiation-Sensitizing Agents/pharmacology , Radiopharmaceuticals/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...